Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

British Journal of Haematology

Volumn 134, Issue 1, 2006, Pages 64-76

  Feuchtinger, Tobias ^a   Matthes Martin, Susanne ^b   Richard, Celine ^a   Lion, Thomas ^b   Fuhrer, Monika ^c   Hamprecht, Klaus ^d   Handgretinger, Rupert ^a   Peters, Christina ^b   Schuster, Friedhelm R ^c   Beck, Robert ^d   Schumm, Michael ^a   Lotfi, Ramin ^d   Jahn, Gerhard ^d   Lang, Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adenovirus infection; Adoptive T cell transfer; Allogeneic stem cell transplantation; Immunotherapy

Indexed keywords

ALEMTUZUMAB; AMSACRINE; BUSULFAN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; GAMMA INTERFERON; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EARLY DIAGNOSIS; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INFECTION RISK; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; VIRUS INFECTION; VIRUS SPECIFIC T CELL IMMUNITY;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOPTIVE TRANSFER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33744788680     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06108.x     Document Type: Article

References (41)

1. Bahceci E. Epperson D. Douek D.C. Melenhorst J.J. Childs R.C. Barrett A.J. 2003 Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. British Journal of Haematology, 122, 934 943.
2. Bordigoni P. Carret A.S. Venard V. Witz F. Le Faou A. 2001 Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical Infectious Disease, 32, 1290 1297.
3. Chakrabarti S. Collingham K.E. Fegan C.D. Pillay D. Milligan D.W. 2000 Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplantation, 26, 305 307.
4. Chakrabarti S. Mautner V. Osman H. Collingham K.E. Fegan C.D. Klapper P.E. Moss P.A. Milligan D.W. 2002 Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood, 100, 1619 1627.
5. De Rosa S.C. Brenchley J.M. Roederer M. 2003 Beyond six colors: a new era in flow cytometry. Nature Medicine, 9, 112 117.
6. Einsele H. Roosnek E. Rufer N. Sinzger C. Riegler S. Loffler J. Grigoleit U. Moris A. Rammensee H.G. Kanz L. Kleihauer A. Frank F. Jahn G. Hebart H. 2002 Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 3916 3922.
7. Feuchtinger T. Lang P. Hamprecht K. Schumm M. Greil J. Jahn G. Niethammer D. Einsele H. 2004 Isolation and expansion of human adenovirus specific CD4+ and CD8+ T-cells according to IFN-gamma secretion for adjuvant immunotherapy. Experimental Hematology, 32, 282 289.
8. Feuchtinger T. Lucke J. Hamprecht K. Richard C. Handgretinger R. Schumm M. Greil J. Bock T. Niethammer D. Lang P. 2005 Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 128, 503 509.
9. Flomenberg P. Babbitt J. Drobyski W.R. Ash R.C. Carrigan D.R. Sedmak G.V. McAuliffe T. Camitta B. Horowitz M.M. Bunin N. 1994 Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Disease, 169, 775 781.
10. Flomenberg P. Piaskowski V. Truitt R.L. Casper J.T. 1995 Characterisation of human proliferative T cell responses to adenovirus. Journal of Infectious Disease, 171, 1090 1096.
11. Gattinoni L. Klebanoff C.A. Palmer D.C. Wrzesinski C. Kerstann K. Yu Z. Finkelstein S.E. Theoret M.R. Rosenberg S.A. Restifo N.P. 2005 Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. Journal of Clinical Investigation, 115, 1616 1626.
12. Gavin P.J. Katz B.Z. 2002 Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics, 110, e9.
13. Handgretinger R. Lang P. Schumm M. Pfeiffer M. Gottschling S. Demirdelen B. Bader P. Kuci S. Klingebiel T. Niethammer D. 2001 Immunological aspects of haploidentical stem cell transplantation in children. Annals of the New York Academy of Science, 938, 340 357.
14. Heemskerk B. Veltrop-Duits L.A. van Vreeswijk T. ten Dam M.M. Heidt S. Toes R.E. van Tol M.J. Schilham M.W. 2003 Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. Journal of Virology, 77, 6562 6566.
15. Heemskerk B. Lankester A.C. van Vreeswijk T. Beersma M.F. Claas E.C. Veltrop-Duits L.A. Kroes A.C. Vossen J.M. Schilham M.W. van Tol M.J. 2005 Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. Journal of Infectious Disease, 191, 520 530.
16. Heim A. Ebnet C. Harste G. Pring-Akerblom P. 2003 Rapid and quantitative detection of human adenovirus DNA by real-time PCR. Journal of Medical Virololgy, 70, 228 239.
17. Howard D.S. Phillips II., G.L. Reece D.E. Munn R.K. Henslee-Downey J. Pittard M. Barker M. Pomeroy C. 1999 Adenovirus infections in hematopoietic stem cell transplant recipients. Clinical Infectious Disease, 29, 1494 1501.
18. Hromas R. Cornetta K. Srour E. Blanke C. Broun E.R. 1994 Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood, 84, 1689 1690.
19. Kampmann B. Cubitt D. Walls T. Naik P. Depala M. Samarasinghe S. Robson D. Hassan A. Rao K. Gaspar H. Davies G. Jones A. Cale C. Gilmour K. Real M. Foo M. Bennett-Rees N. Hewitt A. Amrolia P. Veys P. 2005 Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. British Journal of Haematology, 130, 595 603.
20. Kojaoghlanian T. Flomenberg P. Horwitz M.S. 2003 The impact of adenovirus infection on the immunocompromised host. Reviews Medical Virology, 13, 155 171.
21. Lang P. Handgretinger R. Niethammer D. Schlegel P.G. Schumm M. Greil J. Bader P. Engel C. Scheel-Walter H. Eyrich M. Klingebiel T. 2003 Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood, 101, 1630 1636.
22. Lankester A.C. Heemskerk B. Claas E.C. Schilham M.W. Beersma M.F. Bredius R.G. van Tol M.J. Kroes A.C. 2004 Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clinical Infectious Disease, 38, 1521 1525.
23. La Rosa A.M. Champlin R.E. Mirza N. Gajewski J. Giralt S. Rolston K.V. Raad I. Jacobson K. Kontoyiannis D. Elting L. Whimbey E. 2001 Adenovirus infections in adult recipients of blood and marrow transplants. Clinical Infectious Disease, 32, 871 876.
24. Leen A.M. Rooney C.M. 2005 Adenovirus as an emerging pathogen in immunocompromised patients. British Journal of Haematology, 128, 135 144.
25. Leen A.M. Sili U. Vanin E.F. Jewell A.M. Xie W. Vignali D. Piedra P.A. Brenner M.K. Rooney C.M. 2004 Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood, 104, 2432 2440.
26. Legrand F. Berrebi D. Houhou N. Freymuth F. Faye A. Duval M. Mougenot J.F. Peuchmaur M. Vilmer E. 2001 Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplantation, 27, 621 626.
27. Leruez-Ville M. Minard V. Lacaille F. Buzyn A. Abachin E. Blanche S. Freymuth F. Rouzioux C. 2004 Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clinical Infectious Disease, 38, 45 52.
28. Lewin S.R. Heller G. Zhang L. Rodrigues E. Skulsky E. van den Brink M.R. Small T.N. Kernan N.A. O'Reilly R.J. Ho D.D. Young J.W. 2002 Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood, 100, 2235 2242.
29. Lion T. Baumgartinger R. Watzinger F. Matthes-Martin S. Suda M. Preuner S. Futterknecht B. Lawitschka A. Peters C. Potschger U. Gadner H. 2003 Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, 102, 1114 1120.
30. Ljungman P. Ribaud P. Eyrich M. Matthes-Martin S. Einsele H. Bleakley M. Machaczka M. Bierings M. Bosi A. Gratecos N. Cordonnier C. 2003 Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the infectious diseases working party of the European group for blood and marrow transplantation. Bone Marrow Transplantation, 31, 481 486.
31. Mohty M. Jacot W. Faucher C. Bay J.O. Zandotti C. Collet L. Choufi B. Bilger K. Tournilhac O. Vey N. Stoppa A.M. Coso D. Gastaut J.A. Viens P. Maraninchi D. Olive D. Blaise D. 2003 Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia, 17, 2168 2177.
32. Moss P. Rickinson A. 2005 Cellular immunotherapy for viral infection after HSC transplantation. Nature Reviews Immunology, 5, 9 20.
33. Olive M. Eisenlohr L. Flomenberg N. Hsu S. Flomenberg P. 2002 The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Human Gene Therapy, 13, 1167 1178.
34. Riddell S.R. Watanabe K.S. Goodrich J.M. Li C.R. Agha M.E. Greenberg P.D. 1992 Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, 238 241.
35. Rooney C.M. Smith C.A. Ng C.Y. Loftin S.K. Sixbey J.W. Gan Y. Bowman D.K. Krance L.C. Brenner R.A. Srivastava M.K. Heslop H.E. 1998 Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, 1549 1555.
36. Shirali G.S. Ni J. Chinnock R.E. Johnston J.K. Rosenthal G.L. Bowles N.E. Towbin J.A. 2001 Association of viral genome with graft loss in children after cardiac transplantation. New England Journal of Medicine, 344, 1498 1503.
37. Sun J.C. Williams M.A. Bevan M.J. 2004 CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nature Immunology, 5, 927 933.
38. Van Driessche A. Gao L. Stauss H.J. Ponsaerts P. Van Bockstaele D.R. Berneman Z.N. Van Tendeloo V.F. 2005 Antigen-specific cellular immunotherapy of leukemia. Leukemia, 19, 1863 1871.
39. Walls T. Shankar A.G. Shingadia D. 2003 Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infectious Disease, 3, 79 86.
40. Walls T. Hawrami K. Ushiro-Lumb I. Shingadia D. Saha V. Shankar A.G. 2005 Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary Clinical Infectious Disease, 40, 1244 1249.
41. Walter E.A. Greenberg P.D. Gilbert M.J. Finch R.J. Watanabe K.S. Thomas E.D. Riddell S.R. 1995 Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 1038 1044.